Navigation Links
Monoclonal antibody appears effective and safe in asthma Phase IIa trial
Date:5/21/2013

ficant improvements were also reported for other relevant asthma outcomes such as lung function as assessed by forced expiratory volume in one second (FEV1) and morning peak expiratory flow, asthma symptoms and control, as well as, asthma reliever medication use. Many of these improvements were seen when dupilumab was added to ICS/LABA, with efficacy maintained despite background therapy withdrawal.

"Intriguingly," noted Dr. Wenzel, "dupilumab showed substantial efficacy in objective and patient-reported endpoints when added to ICS and LABA and when those therapies were discontinued."

Patients in the study received dupilumab or placebo added to their regular, twice daily dose of fluticasone/salmeterol. At Week 4, patients were instructed to withdraw the LABA (salmeterol). Between Weeks 6 and 9, they tapered off fluticasone, the ICS.

A total of 104 patients, aged 18 to 65, participated in the study. Half received the monoclonal antibody; half received placebo. All had persistent, moderate-to-severe asthma that was not well-controlled by medium to high doses of combined ICS and LABA therapy. The patients also had elevated blood (≥ 300 cells/l) or sputum (≥3%) eosinophils at screening.

The study found no clear change in blood eosinophils with dupilumab therapy; however, other biomarkers decreased, including fractional exhaled nitric oxide, thymus and activation regulated chemokine, immunoglobulin E and eotaxin-3, confirming the biologic activity of dupilumab.

Side effects occurring more frequently in the patients receiving the monoclonal antibody vs. placebo included injection site reactions, nasopharyngitis, nausea and headache, but were not considered severe.

According to Dr. Wenzel, the current study, exhibited a "magnitude and breadth" of efficacy that exceeded other studies of cytokine inhibition in asthma. She and her investigator colleagues speculate that the stronger outcome came as a re
'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
2. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
3. Scientists Pinpoint Antibody That May Be Specific to MS Patients
4. NIH scientists map first steps in flu antibody development
5. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
6. Antibody-coated stents: Indication of disadvantages
7. Evolution in the antibody factory
8. Scientists ID Antibody That Might Boost Cancer Therapy
9. Your Autoantibody Profile Might Someday Help Spot Illness
10. Off-Label Drug Use Appears Common
11. Exercise Appears to Ease Nerve-Damage Pain in Rat Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... ... By 50% or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. ... 15 year veteran of helping drug, biologic and device firms reduce manufacturing errors ...
(Date:7/30/2015)... FL (PRWEB) , ... July 31, 2015 , ... On ... first meeting in Manatee county to discuss plausible solutions for controlling the heroin outbreak. ... the event of an overdose is largely perpetuating the heroin crisis in North Florida. ...
(Date:7/30/2015)... ... July 30, 2015 , ... World Patent Marketing, a ... app invention that can help people during emergencies. , "The worldwide mobile health ... Creative Director of World Patent Marketing. "Currently, there are about 97,000 mobile health ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... BioPharma, Inc. are pleased to announce that data standards for clinical research in ... on the CDISC website . These three Therapeutic Area (TA) standards were ...
(Date:7/30/2015)... ... , ... In an effort to provide the twenty four hour continuous care ... his practice. , The decision will also allow him to spend more time in ... his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has always ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2
... Doctors use diagnostic sonography or ultrasound to visualise organs ... researcher Koos Huijssen has developed a computer model that ... ultrasound instruments. The computer model is capable of processing ... both a PC and a parallel supercomputer. Erasmus University ...
... American Society of,Hematology (ASH), the world,s largest professional ... its Executive Committee, the,governing body of the organization. ... 2009., J. Evan Sadler, MD, PhD, will ... successive terms as president-elect and president. Charles,Abrams, MD, ...
... Nov. 4 Election Day statement by,SEIU President Andy ... Tacoma, Washington, who lost,her home and all her savings ... -- will vote today., "Samara Knight -- a ... can,t afford her mortgage payments and the,medication her son ...
... HOLLYWOOD, Calif., Nov. 4 IPC The,Hospitalist Company, Inc. ... practice company, announced today that Adam D. Singer,Chief Executive ... scheduled to present on Wednesday, November 12, 2008 at ... AZ., Event: 2008 Annual Credit Suisse ...
... Allied Minds funds research to reduce,wrinkles by developing ... a seed investment firm specializing in early stage ... Berkeley National,Laboratory through creation of start-up company, ProGDerm, ... Mina Bissell will develop a,technology based on modulation ...
... Will Sell Programming Kit and Software ,Separately From its Hearing Aids ... ... November 4, 2008 -- America Hears, Inc. , the leading ... improved version of its hearing-aid programming software, Virtual Office, and announced ...
Cached Medicine News:Health News:New Leadership Elected to the American Society of Hematology 2Health News:Today We Must Be the Change We Need 2Health News:IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference 2Health News:New Skin Rejuvenation Discovery Receives Commercial Backing 2Health News:America Hears Introduces New and Improved Hearing-Aid Programming Software 2Health News:America Hears Introduces New and Improved Hearing-Aid Programming Software 3
(Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
(Date:7/31/2015)... N.J. and SAN DIEGO ... that its parent company Eisai Co., Ltd. (Headquarters: ... Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Dr. Helen Torley , "NASDAQ: HALO") have signed ... (brand name: Halaven ® , "eribulin") in combination with ...
(Date:7/31/2015)... 31, 2015  Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... S. Hata to its board of directors. ... corporate development is a tremendous asset to our board," ... executive officer of Xencor. "Xencor faces a range of ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... (NYSE Amex: PIP ), a biodefense company ... today that Eric I. Richman, President and Chief Executive ... Healthcare Conference being held November 29-30, 2011.  ... in one-on-one meetings at the conference.Event : , ...
... 28, 2011  CIVCO Medical Solutions is introducing RAD-GUIDE, ... at RSNA 2011. RAD-GUIDE allows physicians a method ... visualizing and adjusting planned punctures prior to needle ... to translating our expertise in ultrasound needle guidance ...
Cached Medicine Technology:PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011 2CIVCO Enters CT Needle Guidance Market with RAD-GUIDE™ Launch 2
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... Repair CompanySM is pleased to announce the ... Bard Composix E/X mesh.,When Bard Composix mesh ... first ventral hernia repair prosthesis that combined ... and ePTFE, in one product. Bard Composix ...
... 1958, Bard mesh has become the standard ... Bard mesh was used by Dr. Irving ... hernia repair many years ago. Lichtenstein describes ... substance for permanent reinforcement of hernia repair. ...
... mesh is a three-dimensional, anatomically formed prosthesis ... Bard 3DMax mesh has been designed based ... the inguinal canal. The result is a ... Bard 3DMax product is constructed of Bard ...
Medicine Products: